Press release
New Report Examines the Febrile Neutropenia Market Research
The market of febrile neutropenia is majorly driven by the efforts of key players to develop novel and cost effective therapeutics. For example, in July 2014, Taiho Pharmaceutical Co., Ltd. filled an application for approval of ZOSYN 2.25 and ZOSYN 4.5 (generic name- tazobactam piperacillin) for additional indication of febrile neutropenia. This product is a combination of antibacterial β-lactamase inhibitor and can be used intravenously. Moreover, in April 2014, Amgen, Inc. collaborated with ONS Edge, Inc. to help educate nurses regarding the patients who are at the risk of febrile neutropenia.
Obtain Report Details @ https://www.transparencymarketresearch.com/febrile-neutropenia-market.html
Thus, these types of efforts will build healthy platform to develop the market of febrile neutropenia hence stimulates the market growth. Additionally, large number of therapeutics under clinical pipelines by key companies will further stimulate the market growth in near future. Positive initiatives by North American and European governments will further drive the market growth of febrile neutropenia.
For example, in September 2013, U.S. Food Drug and Administration (U.S. FDA) approved phase III study of Neulasta (pegfilgrastim) by Amgen, Inc. This study demonstrates increase of white blood cells in patients who are undergoing myelo-suppressive chemotherapy. In addition, in June 2010, Nivestim (TM), a new biosimilar filgrastim by Hospira, Inc. is approved by European Commission. This drug is mainly used for the prevention of febrile neutropenia and offers cost-effective treatment option for neutropenia.
However, lack of specific treatment that enables to treat all the symptoms of this disorder may restrain the growth of this market. In addition, high generic competition among the key players leads to price erosion and ultimately restrains the overall growth of febrile neutropenia market.
Geographically, North America dominates the global febrile neutropenia market. High degree of therapeutic needs for febrile neutropenia coupled with presence of large number of key players like Amgen, Inc., Aequus BioPharma, Inc. and others in North American market will drive the growth of the market. Europe is considered as the second largest market of febrile neutropenia. Large pool of patients under the diagnosis of this disease coupled with increasing demand of treatment fuels the growth of febrile neutropenia market.
In addition, Asia-Pacific region is considered as an emerging market for febrile neutropenia due to the launch of novel drugs with improved efficacy by key companies. In addition, growing awareness for this disorder among the people will further stimulate the growth of febrile neutropenia market in Asia-Pacific region.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2857
Some of the key players in the febrile neutropenia market include Xenetic Biosciences plc, Richter Gedeon Nyrt., Amgen, Inc., Hospira, Inc., Eli Lilly and Company, USV Limited, Aequus BioPharma, Inc., Taiho Pharmaceutical Co., Ltd. and others.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Report Examines the Febrile Neutropenia Market Research here
News-ID: 888309 • Views: …
More Releases from Transparency Market Research
Photo-rechargeable Battery Industry Set to Exceed USD 399.2 Mn by 2031, Driven b …
The global photo-rechargeable batteries market, valued at US$ 90.0 million in 2022, is poised for robust expansion. With an anticipated CAGR of 18.9% from 2023 to 2031, the market is projected to reach US$ 399.2 million by the end of 2031. Growth is primarily driven by rising demand for sustainable energy solutions, increased adoption of consumer electronics and wearable devices, and ongoing technological innovations in solar rechargeable battery technologies.
Uncover essential…
Energy Recovery Technologies Industry Projected to Grow at 6.1% CAGR, Reaching U …
The global energy recovery technologies market, valued at US$ 33.1 billion in 2022, is set to grow at a CAGR of 6.1% from 2023 to 2031, reaching US$ 53.2 billion by the end of 2031. Rising demand for energy-efficient solutions, increasing energy costs, and heightened awareness about climate change are driving market growth as industries seek to reduce their carbon footprints by recovering waste heat and converting it into usable…
Coin Cells Market Projected to Reach USD 5.9 Bn by 2031 with 4.5% CAGR - Transpa …
The global coin cells market, valued at US$ 4.0 billion in 2022, is set for steady growth over the forecast period. With an anticipated CAGR of 4.5% from 2023 to 2031, the market is projected to reach US$ 5.9 billion by the end of 2031. This growth is driven by the increasing demand for compact and long-lasting power sources for wearable IoT devices, portable electronics, and renewable energy storage applications.
Uncover…
Printed Battery Market to Reach USD 1.8 Billion by 2031, Growing at an Impressiv …
The global printed battery market, valued at US$ 166.0 million in 2022, is expected to experience remarkable growth over the forecast period. With an estimated CAGR of 30.1% from 2023 to 2031, the market is projected to reach US$ 1.8 billion by the end of 2031. This growth is primarily driven by the rising adoption of IoT devices and the increasing demand for wearable and flexible electronics, which are fueling…
More Releases for Febrile
Febrile Neutropenia Market Growth Prospects, Trends and Forecast up to 2030
Regular Patient Monitoring Reduces Stress on Clinicians amidst COVID-19 Outbreak
Patients with febrile neutropenia are at a high risk of contracting the coronavirus (COVID-19) infection. Hence, pharma companies in the febrile neutropenia market are increasing their production capabilities to manufacture intravenous (IV) antibiotics to avoid supply shocks in healthcare settings. Manufacturers are educating clinicians to conduct regular computed tomography (CT) scan of the chest of febrile neutropenia patients even in the…
Febrile Neutropenia Market Significantly Stepping towards the Success Till 2027
Alpha-2 antiplasmin, commonly known as a plasmin inhibitor, is a glycoprotein made by the liver, kidneys, and other bodily organs. Alpha-2 Antiplasmin is a serine protease inhibitor belonging to the Serpin superfamily that is responsible for the breakdown of fibrin clots and the inhibition of fibrinolysis. Due to an increase in fibrinolysis, a lack of Alpha 2 antiplasmin causes bleeding problems. Internal bleeding is caused by a congenital lack of…
Global Febrile Antigen Kits Market Huge Growth Opportunity between 2020-2025
LP INFORMATION recently released a research report on the Febrile Antigen Kits market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Febrile Antigen Kits market by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Febrile Antigen Kits market, market definition, overview,…
Febrile Neutropenia Market Forecast, Overview and Cost Structure Analysis to 202 …
The Febrile Neutropenia Market report offers a deep analysis of the Febrile Neutropenia trade. It demonstrates a quick outline of trade knowledge and key Information like Key Manufacturers , Types, Application, Table Of Content, etc of the market. The report highlights Top Venders from the worldwide and Febrile Neutropenia Market along with their worth of the Industry to see their progress. The worldwide Febrile Neutropenia analysis report covers recent enhancements…
Febrile Neutropenia Market : Growth Opportunities & Technology Developments by 2 …
Febrile neutropenia is defined as the development of fever with sign of infection. Febrile neutropenia is one of the most severe complications during cancer chemotherapy and is mainly caused by infectious agents like gram positive and gram negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. Blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally,…
Febrile Neutropenia Market Current Trends and Future Aspect Analysis 2020
Febrile neutropenia is defined as the development of fever with sign of infection. Febrile neutropenia is one of the most severe complications during cancer chemotherapy and is mainly caused by infectious agents like gram positive and gram negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. Blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally,…
